SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-110002
Filing Date
2022-10-19
Accepted
2022-10-19 16:37:00
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.RAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2228586d1_sc13da.htm SC 13D/A 76322
  Complete submission text file 0001104659-22-110002.txt   78258
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92879 | Film No.: 221318985
SIC: 2834 Pharmaceutical Preparations